Atlanta, GA, United States of America

Viswatej Vemulapalli

This inventor holds 1 USPTO granted patent. Top assignee: Solvay Pharmaceuticals, B.v.. Active years: 2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Viswatej Vemulapalli. Retrieved from https://idiyas.com/inventor/viswatej-vemulapalli

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2009

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Viswatej Vemulapalli: Innovator in Transdermal Drug Delivery

Introduction

Viswatej Vemulapalli is an accomplished inventor based in Atlanta, GA (US). He has made significant contributions to the field of pharmaceuticals, particularly in drug delivery systems. His innovative approach has led to the development of a unique method for delivering therapeutic compounds.

Latest Patents

Viswatej holds a patent for the "Transdermal iontophoretic delivery of piperazinyl-2(3H)-benzoxazolone compounds." This invention relates to an iontophoretic method for the delivery of a specific compound formula. The patent also encompasses iontophoretic systems and kits that combine the delivery system with cartridges containing the compound.

Career Highlights

Viswatej is currently associated with Solvay Pharmaceuticals B.V., where he continues to advance his research and development efforts. His work focuses on improving drug delivery methods, which can enhance patient outcomes and treatment efficacy.

Collaborations

Throughout his career, Viswatej has collaborated with notable professionals in the field, including Johanna Aaltje Bouwstra and Dirk-Jan Van Den Berg. These collaborations have contributed to the advancement of his research and the successful development of innovative solutions.

Conclusion

Viswatej Vemulapalli is a prominent figure in the realm of pharmaceutical innovations, particularly in transdermal drug delivery systems. His contributions are paving the way for more effective therapeutic solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…